Skip Navigation


European Heart Journal Advance Access originally published online on September 14, 2007
European Heart Journal 2007 28(20):2427-2429; doi:10.1093/eurheartj/ehm367
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/20/2427    most recent
ehm367v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Christoffersen, C.
Right arrow Articles by Goetze, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christoffersen, C.
Right arrow Articles by Goetze, J. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org

Diabetes and the endocrine heart

Christina Christoffersen1, Ingrid Hunter2, Asger Lundorff Jensen2 and Jens Peter Goetze1,*

1 Department of Clinical Biochemistry
2 Small Animal Clinical Sciences, University of Copenhagen, Copenhagen, Denmark

* Corresponding author. Tel: +45 35452202; fax: +45 3545 4640. E-mail address; JPG@dadlnet.dk

This editorial refers to ‘Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy’ by E. Konduracka et al., on page 2465

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

The first 150 words of the full text of this article appear below.

Diabetes mellitus is a disease with major clinical relevance in the cardiological setting. Diabetes predisposes to atherosclerosis and myocardial damage often requiring acute cardiological intervention and long-term treatment. As the common type 2 form of diabetes can go undiagnosed for many years, cardiologists will often also be the first clinicians to diagnose the metabolic disorder in patients presenting with diabetes-related complications. Thus, primary diagnosis, initial treatment, and long-term glycaemic control of diabetes are all an integral part of cardiology.

B-type natriuretic peptide (BNP) and molecular fragments of its precursor (NT-proBNP) are useful plasma markers in cardiac disease.1 Low plasma concentrations can exclude severe systolic cardiac dysfunction, whereas increased concentrations favour—but are not specific for—a diagnosis of heart failure. These markers also look promising in differentiating . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy
Ewa Konduracka, Andrzej Gackowski, Pawel Rostoff, Danuta Galicka-Latala, Wieslaw Frasik, and Wieslawa Piwowarska
EHJ 2007 28: 2465-2471. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Eur Heart JHome page
M. Huelsmann, S. Neuhold, G. Strunk, D. Moertl, R. Berger, R. Prager, H. Abrahamian, M. Riedl, R. Pacher, A. Luger, et al.
NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
Eur. Heart J., September 2, 2008; 29(18): 2259 - 2264.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
T. D. Karamitsos, A. Tsapas, and J. R. Arnold
Diabetic cardiomyopathy: a controversial entity
Eur. Heart J., February 2, 2008; 29(4): 564 - 564.
[Full Text] [PDF]